Americord Launches Corporate Giving Program

April 8, 2014

Funds Will Support the Advancement of Cutting Edge Stem Cell Research Worldwide

NEW YORK, April 8, 2014 /PRNewswire/ — Americord announced today the launch of its corporate giving program, which will support research focused on the therapeutic uses of stem cells from umbilical cord blood, cord tissue and placenta tissue. In addition to ongoing and future clinical trials focused on a broad array of diseases, conditions, and injuries, Americord’s corporate giving program may also fund research related to stem cell technologies with broad applications in the field.

“Americord is committed to supporting doctors and scientists worldwide who are at the cutting edge of research into even more and better stem cell-based medical therapies than already exist today,” said Americord CEO Martin Smithmyer. “Stem cells are opening up a new frontier in the treatment and cure of the most complex diseases, conditions, and injuries, and we want to do our part to help the men and women who are leading the charge into the future of health care.”

Americord decided to launch its corporate giving program to further its commitment to being a leader in the cord blood banking industry. It is one of just a handful of cord blood banks that have an established program to support stem cell research. Americord has already invested significant resources in the development of CordAdvantage, a proprietary product due to be released later this year that will harvest stem cells from cord blood from the placenta as well as the umbilical cord.

About Americord Registry

Americord is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord’s website at cordadvantage.com for more information. You may also find Americord on Facebook and follow the company on Twitter.

    Contact:                  Andrew Flook

                              Americord Registry



SOURCE Americord

Source: PR Newswire

comments powered by Disqus